Where can I find the actual financial results for the quarter ended June 30, 2025?

The specific financial results for the quarter ended June 30, 2025, are detailed in the press release furnished as Exhibit 99.1 to this 8-K filing. Investors should refer to Exhibit 99.1 for quantitative performance data.

Is the information in this 8-K filing considered 'filed' with the SEC for legal purposes?

No, the information furnished in Item 2.02 of this 8-K and its exhibits, including the press release, is specifically stated as not being 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934. This means it does not carry the same legal liability as formally filed information.

What are the main risks Elevance Health is highlighting regarding its future performance?

Elevance Health highlights several risks that could affect future performance, including fluctuations in healthcare costs and utilization, changes in enrollment, the impact of new or existing healthcare regulations, potential data security breaches, and competitive market pressures. These are detailed in the forward-looking statements section of the filing and the referenced press release.

Does this filing provide updated financial guidance for the rest of the year?

This 8-K filing itself does not provide detailed financial guidance. The press release (Exhibit 99.1) is the document that would typically contain updated financial projections or guidance from the company for the remainder of the fiscal year.

ELV 8-K: Earnings & Results

Summary

Elevance Health, Inc. (ELV) has filed a Current Report (8-K) on July 17, 2025, to report its financial results for the fiscal quarter ended June 30, 2025. The primary purpose of this filing is to furnish a press release detailing these results, which is included as an exhibit. Investors should note that the information provided in this Item 2.02 and the attached press release is furnished and not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, nor will it be automatically incorporated into future SEC filings unless specifically referenced. While the specific financial figures are not detailed within the 8-K text itself but are contained within the referenced press release (Exhibit 99.1), this filing serves as official notification of the company's quarterly performance disclosure. Investors are advised to consult the press release for detailed financial metrics, including revenue, earnings, and any guidance provided. The filing also includes standard forward-looking statement disclaimers, highlighting the inherent risks and uncertainties associated with such projections, which could cause actual results to differ materially from expectations.

Key Highlights

1Elevance Health announced its financial results for the quarter ended June 30, 2025, via an 8-K filing on July 17, 2025.
2The press release containing the detailed financial results is furnished as Exhibit 99.1 to the 8-K filing.
3Information furnished in this 8-K is not considered 'filed' for SEC liability purposes under Section 18 of the Securities Exchange Act of 1934.
4The company includes standard forward-looking statement disclaimers, cautioning investors about the inherent risks and uncertainties in projections.
5Potential risks mentioned that could impact future results include healthcare costs, enrollment trends, regulatory changes, data security incidents, and competitive pressures.
6Investors are directed to the press release (Exhibit 99.1) for specific financial performance details and forward-looking guidance.

Elevance Health, Inc. 8-K Report, Financial Results (Jul 17, 2025)

Summary

Key Highlights

Frequently Asked Questions